218 related articles for article (PubMed ID: 23744352)
1. Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program.
Lansu K; Gentile S
Cell Death Dis; 2013 Jun; 4(6):e652. PubMed ID: 23744352
[TBL] [Abstract][Full Text] [Related]
2. hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism.
Perez-Neut M; Rao VR; Gentile S
Oncotarget; 2016 Sep; 7(37):58893-58902. PubMed ID: 25945833
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643.
Grunnet M; Abbruzzese J; Sachse FB; Sanguinetti MC
Mol Pharmacol; 2011 Jan; 79(1):1-9. PubMed ID: 20876384
[TBL] [Abstract][Full Text] [Related]
4. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
Hansen RS; Diness TG; Christ T; Demnitz J; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Jan; 69(1):266-77. PubMed ID: 16219910
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643.
Durdagi S; Guo J; Lees-Miller JP; Noskov SY; Duff HJ
J Pharmacol Exp Ther; 2012 Aug; 342(2):441-52. PubMed ID: 22573844
[TBL] [Abstract][Full Text] [Related]
6. Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators.
Guo J; Durdagi S; Changalov M; Perissinotti LL; Hargreaves JM; Back TG; Noskov SY; Duff HJ
PLoS One; 2014; 9(9):e105553. PubMed ID: 25191697
[TBL] [Abstract][Full Text] [Related]
7. Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells.
Wu SN; Peng H; Chen BS; Wang YJ; Wu PY; Lin MW
Mol Pharmacol; 2008 Dec; 74(6):1696-704. PubMed ID: 18809671
[TBL] [Abstract][Full Text] [Related]
8. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.
Perissinotti LL; Guo J; De Biase PM; Clancy CE; Duff HJ; Noskov SY
Biophys J; 2015 Mar; 108(6):1414-1424. PubMed ID: 25809254
[TBL] [Abstract][Full Text] [Related]
9. Strong activation of ether-à-go-go-related gene 1 K+ channel isoforms by NS1643 in human embryonic kidney 293 and Chinese hamster ovary cells.
Schuster AM; Glassmeier G; Bauer CK
Mol Pharmacol; 2011 Nov; 80(5):930-42. PubMed ID: 21856740
[TBL] [Abstract][Full Text] [Related]
10. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
Li P; Chen X; Zhang Q; Zheng Y; Jiang H; Yang H; Gao Z
J Pharmacol Exp Ther; 2014 Dec; 351(3):596-604. PubMed ID: 25232191
[TBL] [Abstract][Full Text] [Related]
11. NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation.
Guo J; Cheng YM; Lees-Miller JP; Perissinotti LL; Claydon TW; Hull CM; Thouta S; Roach DE; Durdagi S; Noskov SY; Duff HJ
Biophys J; 2015 Mar; 108(6):1400-1413. PubMed ID: 25809253
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells.
Perez-Neut M; Shum A; Cuevas BD; Miller R; Gentile S
Oncotarget; 2015 Jan; 6(3):1631-9. PubMed ID: 25596745
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of a novel human ether-a-go-go-related gene channel activator.
Casis O; Olesen SP; Sanguinetti MC
Mol Pharmacol; 2006 Feb; 69(2):658-65. PubMed ID: 16284303
[TBL] [Abstract][Full Text] [Related]
14. Activation of ERG2 potassium channels by the diphenylurea NS1643.
Elmedyb P; Olesen SP; Grunnet M
Neuropharmacology; 2007 Aug; 53(2):283-94. PubMed ID: 17610913
[TBL] [Abstract][Full Text] [Related]
15. Frequency-dependent modulation of KCNQ1 and HERG1 potassium channels.
Diness TG; Hansen RS; Olesen SP; Grunnet M
Biochem Biophys Res Commun; 2006 May; 343(4):1224-33. PubMed ID: 16581021
[TBL] [Abstract][Full Text] [Related]
16. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
[TBL] [Abstract][Full Text] [Related]
17. Effects of the small molecule HERG activator NS1643 on Kv11.3 channels.
Bilet A; Bauer CK
PLoS One; 2012; 7(11):e50886. PubMed ID: 23226420
[TBL] [Abstract][Full Text] [Related]
18. Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma.
Perez-Neut M; Haar L; Rao V; Santha S; Lansu K; Rana B; Jones WK; Gentile S
Oncotarget; 2016 Apr; 7(16):21991-2004. PubMed ID: 26942884
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
20. HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96.
Feng J; Yu J; Pan X; Li Z; Chen Z; Zhang W; Wang B; Yang L; Xu H; Zhang G; Xu Z
Oncotarget; 2014 Jul; 5(14):5832-44. PubMed ID: 25071021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
